Patents Assigned to INSTITUE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE)
  • Imidazo[4,5-B]Pyridin-2-One and Oxazolo[4,5-B]Pyridin-2-One Compounds and Analogs Thereof as Therapeutic Compounds
    Publication number: 20070287838
    Abstract: The present invention pertains to certain imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof, which, inter alia, inhibit RAF (e.g., B-RAF) activity, inhibit cell proliferation, treat cancer, etc.
    Type: Application
    Filed: October 21, 2005
    Publication date: December 13, 2007
    Applicants: CANCER RESEARCH TECHNOLOGY LIMITED, INSTITUE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE), ASTEX THERAPEUTICS LIMITED
    Inventors: Dan Niculescu-Duvaz, Caroline Springer, Adrian Gill, Richard Taylor, Richard Marais, Hermen Dijkstra, Catherine Gaulon, Delphine Menard, Esteban Roman Vela